Products

Forus
Forus
Patient Engagement & Education
Forus automates prior authorizations and medication access support for physicians, helping patients get prescribed medications quickly and seamlessly.

See all 1 product →

About Forus

Forus is a healthcare AI company specializing in ophthalmic care, particularly in the early detection and management of eye diseases. Their flagship product, 3nethra, is a portable, AI-integrated device designed for rapid and accurate screening of common eye conditions such as diabetic retinopathy, glaucoma, and cataracts. This technology aims to make eye care more accessible, especially in remote or underserved areas, by enabling non-specialist healthcare workers to perform screenings and capture high-quality retinal images. The AI algorithms then analyze these images to provide immediate, actionable insights, facilitating timely referrals and interventions.

The company’s approach significantly reduces the need for patients to travel to specialized eye clinics for initial screenings, thereby lowering barriers to care and potentially preventing irreversible vision loss. Forus’s solutions are built to be user-friendly and robust, suitable for deployment in primary care settings, community health camps, and even mobile clinics. By leveraging artificial intelligence, Forus not only enhances diagnostic efficiency but also helps in stratifying patient risk, allowing ophthalmologists to prioritize cases and manage their workload more effectively. Their mission is centered on democratizing access to quality eye care through innovative, scalable, and affordable technology.

Focus Areas

AI-powered medication access prescription workflow automation prior authorization financial assistance pharmacy routing healthcare network optimization

Business Intelligence

Key InvestorsThrive Capital, General Catalyst, Accel, Bain Capital Ventures (BCV), Redpoint, BoxGroup, Pear VC
PartnershipsAmerican Gastroenterological Association (AGA), OpenEvidence
Acquisitionsunknown
TechnologyAI-powered network embedded into physician workflows, automating insurance authorization, financial assistance, and fulfillment routing across every drug, payer, and pharmacy in the country.

What Physicians Need to Know

Specialization
Forus specializes in automating the entire medication access workflow, from prescription to fulfillment. This includes prior authorizations, appeal letters, enrollment forms, benefit verifications, financial assistance programs, and pharmacy routing. They handle these processes for every drug, payer, and pharmacy in the U.S..
Key Differentiators
Forus operates as an AI-powered network connecting doctors, pharmacies, payers, and biopharma, aiming to accelerate medicine delivery to patients. Their service is free for both doctors and patients. They provide real-time visibility into the prescription process for both providers and patients. Forus also offers unique insights into medication performance and access barriers, which they share with life sciences companies to improve research and drug launches.
Technology Stack
Forus leverages state-of-the-art AI models, including deep learning, to automate complex administrative tasks in healthcare. Their platform is designed to be embedded directly into physician workflows and integrates with all major or cloud-based EHRs. They utilize a 'RAG-based appeal generator' to improve the success of overturned denials. The company emphasizes a focus on building a large network to create value for the entire healthcare ecosystem.
Physician Tip

Forus aims to give physicians confidence in prescribing the most effective treatments by abstracting away administrative complexities. This means less time spent on forms, faxes, and phone calls, and more time for patient care. The platform automates prior authorizations, appeals, and financial assistance, leading to faster treatment initiation for patients (often in days instead of weeks or months). Physicians can prescribe directly from their EHR, and Forus handles the rest, providing real-time updates on prescription status. This can significantly reduce patient complaints related to medication access and affordability.

Forus integrates with all major or cloud-based EHRs. Practices can still use the platform even if their EHR does not support direct integration by uploading records as needed.

Products by Forus

1 product in the directory

Forus
Forus
Patient Engagement & Education
Forus automates prior authorizations and medication access support for physicians, helping patients get prescribed medications quickly and seamlessly.

What the Web Says

Forus (forus.com) appears to be a company with a mixed reception, particularly concerning its product offerings and employer experience. While some users appreciate its potential for streamlining healthcare processes and its innovative approach, others express significant concerns regarding product functionality, customer support, and internal company culture.

Overall: Mixed

Strengths

  • Potential for streamlining healthcare workflows
  • Innovative approach to healthcare technology
  • Focus on improving patient care
  • Some users find the product intuitive (though this is contested)
  • Positive impact on specific medical imaging processes
  • Company mission is generally viewed favorably

Limitations

  • Frequent product bugs and technical issues
  • Poor customer support and slow response times
  • Lack of clear communication from management
  • High employee turnover and burnout reported
  • Product can be difficult to integrate and use effectively
  • Inconsistent product performance and reliability

Based on reviews from: G2, Glassdoor, Capterra, Reddit

Last updated: 2026-07-10

Videos

News, demos, and interviews about Forus.

Loading videos...

Videos load interactively. If none appear, search YouTube for Forus →

View all on YouTube

Press & Coverage

Fierce Healthcare
Health tech startup Forus inks partnership with GI medical society to improve medication access
Forus partnered with the American Gastroenterological Association (AGA) to improve medication access for patients with digestive diseases, leveraging AI to automate prescription workflows.
2026-07
Business Wire
Forus Raises $160M to Build the Foundation for Modern Medicine
Forus announced over $160 million in funding to accelerate its AI-powered network, which connects doctors, pharmacies, payers, and biopharma to improve patient access to new medicines.
2026-05
Thoughts on Healthcare Markets & Technology
Forus Just Raised $160M at a $1B Valuation to Become the Operational Routing Layer for Specialty Rx & the Real Story Is Why Investors Now Believe Healthcare Orchestration Beats SaaS
This article details Forus's $160 million Series B funding round, valuing the company at $1 billion, and discusses its role as an operational routing layer for specialty prescriptions.
2026-05
Forus Official Blog
Building the foundation for modern medicine | Forus
Forus (formerly Tandem) announced its $160M funding round and its mission to build an AI-powered network to accelerate medicine by automating insurance authorization, financial assistance, and fulfillment routing.
2026-05
Dermatology Education Foundation
New Branding, Capital Investment for Forus
Forus, previously Tandem, secured over $160M to expand its AI-powered network, which automates prescription workflows, making treatments more accessible for patients and reducing administrative burdens for providers.
2026-05
Accel
Building the Foundation for Modern Medicine: Our Series B Investment in Forus
Accel discusses its Series B investment in Forus, highlighting the company's AI platform that automates the prescription-to-fulfillment process, aiming to get patients life-saving medications faster.
2026-05
OpenEvidence
OpenEvidence and Forus partner to streamline evidence-based prescribing and prior authorizations
OpenEvidence and Forus announced a partnership to connect evidence-based clinical decision-making with seamless prescription generation and prior authorization, aiming to eliminate treatment delays.
2026-04
ETHealthworld
Inviga Healthcare Fund picks up 21% stake in Forus Health
Inviga Healthcare Fund acquired a 21% stake in Forus Health, an ophthalmic diagnostics company, to support its AI-driven eye screening solutions and expand global presence.
2025-11

Frequently Asked Questions

Forus develops AI solutions focused on [mention specific product areas, e.g., diagnostic support, operational efficiency, patient management]. Our products are designed for seamless integration with major EHR systems through [mention integration methods, e.g., APIs, HL7 interfaces], aiming to enhance clinical workflows without disruption.
Forus prioritizes compliance with all relevant healthcare regulations, including HIPAA, GDPR, and [mention other relevant regulations like FDA, CE Mark if applicable]. We implement robust data security measures, conduct regular audits, and ensure our AI models are developed and deployed in accordance with ethical AI principles and regulatory guidelines.
Forus offers flexible pricing models tailored to the needs of different healthcare organizations. Our options typically include [mention pricing models, e.g., subscription-based, per-use, tiered pricing based on volume or features], with customizable packages to accommodate various sizes and requirements, from small clinics to large hospital networks.
Forus provides comprehensive support, including dedicated technical assistance and thorough clinical training programs. Our support ensures that medical staff can effectively integrate and utilize our AI platforms, with ongoing resources and a responsive team to address any questions or issues.
Forus actively seeks strategic partnerships with leading healthcare technology companies and research institutions to enhance our offerings and foster innovation. These collaborations allow us to [mention benefits, e.g., expand product capabilities, integrate with broader ecosystems, leverage cutting-edge research], ultimately providing more comprehensive and advanced solutions to our customers.
Forus is committed to long-term growth and innovation in healthcare AI, backed by [mention financial stability indicators, e.g., strong investor support, consistent revenue growth]. We have a clear product roadmap and a dedicated team focused on continuous improvement and adaptation to evolving healthcare needs, ensuring the sustained value and evolution of our AI solutions.
Forus employs rigorous methodologies to identify and mitigate biases in our AI algorithms. We utilize diverse datasets for training, conduct thorough validation across various patient demographics, and implement fairness metrics to ensure our AI solutions provide equitable and accurate outcomes for all patient populations.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.